venBio Select Advisor as of March 31, 2017
Portfolio Holdings for venBio Select Advisor
venBio Select Advisor holds 42 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunomedics | 8.5 | $68M | 11M | 6.47 | |
| Tesaro | 7.9 | $63M | 412k | 153.87 | |
| Medicines Company | 7.2 | $58M | 1.2M | 48.90 | |
| ACADIA Pharmaceuticals (ACAD) | 7.0 | $56M | 1.6M | 34.38 | |
| BioMarin Pharmaceutical (BMRN) | 6.5 | $52M | 590k | 87.78 | |
| Array BioPharma | 5.2 | $42M | 4.6M | 8.94 | |
| Dermira | 5.1 | $41M | 1.2M | 34.11 | |
| Amicus Therapeutics (FOLD) | 4.5 | $36M | 5.1M | 7.13 | |
| Lion Biotechnologies | 4.2 | $34M | 4.6M | 7.45 | |
| Clovis Oncology | 3.8 | $31M | 480k | 63.67 | |
| Global Blood Therapeutics In | 3.8 | $30M | 815k | 36.85 | |
| Teligent | 3.7 | $30M | 3.8M | 7.81 | |
| Seattle Genetics | 3.5 | $28M | 450k | 62.86 | |
| Ascendis Pharma A S (ASND) | 2.5 | $20M | 701k | 28.00 | |
| Aerie Pharmaceuticals | 2.4 | $19M | 425k | 45.35 | |
| Pacira Pharmaceuticals (PCRX) | 2.3 | $19M | 410k | 45.60 | |
| Assembly Biosciences | 2.2 | $18M | 696k | 25.49 | |
| Avexis | 2.1 | $17M | 225k | 76.03 | |
| Neuroderm Ltd F | 2.0 | $16M | 590k | 26.55 | |
| BioCryst Pharmaceuticals (BCRX) | 1.7 | $14M | 1.6M | 8.40 | |
| Agenus | 1.6 | $13M | 3.4M | 3.77 | |
| Mirati Therapeutics | 1.6 | $12M | 2.4M | 5.20 | |
| Vanda Pharmaceuticals (VNDA) | 1.1 | $8.6M | 617k | 14.00 | |
| Veracyte (VCYT) | 1.0 | $8.3M | 907k | 9.18 | |
| Alimera Sciences | 1.0 | $8.1M | 5.8M | 1.40 | |
| Cascadian Therapeutics | 0.9 | $7.5M | 1.8M | 4.14 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.9 | $7.4M | 3.8M | 1.95 | |
| Blueprint Medicines (BPMC) | 0.8 | $6.6M | 165k | 39.99 | |
| Axovant Sciences | 0.7 | $5.7M | 385k | 14.94 | |
| Viveve Med | 0.7 | $5.6M | 890k | 6.33 | |
| Sorrento Therapeutics (SRNE) | 0.6 | $4.7M | 1.2M | 3.95 | |
| Akebia Therapeutics (AKBA) | 0.5 | $4.2M | 456k | 9.20 | |
| Fortress Biotech | 0.5 | $3.7M | 997k | 3.70 | |
| Corvus Pharmaceuticals (CRVS) | 0.3 | $2.5M | 122k | 20.77 | |
| AVEO Pharmaceuticals | 0.3 | $2.3M | 3.9M | 0.59 | |
| Cellectis S A (CLLS) | 0.3 | $2.3M | 97k | 24.00 | |
| Oncobiologics | 0.2 | $1.8M | 684k | 2.68 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.2 | $1.7M | 6.0M | 0.28 | |
| Bellicum Pharma | 0.2 | $1.5M | 125k | 12.34 | |
| Trillium Therapeutics, Inc. Cmn | 0.2 | $1.4M | 227k | 6.15 | |
| Oncobiologics Inc *w exp 02/18/201 | 0.0 | $187k | 233k | 0.80 | |
| Oncobiologics Inc *w exp 05/18/201 | 0.0 | $117k | 233k | 0.50 |
